Cargando…

A curcumin analog GL63 inhibits the malignant behaviors of hepatocellular carcinoma by inactivating the JAK2/STAT3 signaling pathway via the circular RNA zinc finger protein 83/microRNA‐324‐5p/cyclin‐dependent kinase 16 axis

BACKGROUND AND AIM: (1E,4E)‐1,5‐bis(2‐bromophenyl) penta‐1,4‐dien‐3‐one (GL63) is a curcumin analog that can protect against carcinogenesis in hepatocellular carcinoma (HCC). The aim of this study was to explore the molecular mechanism of GL63 in HCC. METHODS: Cell viability was examined by cell cou...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Ji‐an, Nie, Wenjia, Dong, Liang, Liu, Wencong, Wei, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518784/
https://www.ncbi.nlm.nih.gov/pubmed/33982329
http://dx.doi.org/10.1111/jgh.15545
_version_ 1784584305052221440
author Zhao, Ji‐an
Nie, Wenjia
Dong, Liang
Liu, Wencong
Wei, Wei
author_facet Zhao, Ji‐an
Nie, Wenjia
Dong, Liang
Liu, Wencong
Wei, Wei
author_sort Zhao, Ji‐an
collection PubMed
description BACKGROUND AND AIM: (1E,4E)‐1,5‐bis(2‐bromophenyl) penta‐1,4‐dien‐3‐one (GL63) is a curcumin analog that can protect against carcinogenesis in hepatocellular carcinoma (HCC). The aim of this study was to explore the molecular mechanism of GL63 in HCC. METHODS: Cell viability was examined by cell counting kit‐8 (CCK‐8) assay. Circular RNA zinc finger protein 83 (circZNF83), microRNA‐324‐5p (miR‐324‐5p), and cyclin‐dependent kinase 16 (CDK16) levels were measured via the quantitative real‐time polymerase chain reaction (qRT‐PCR). Cell proliferation was assessed using colony formation assay. Flow cytometry was performed for detecting cell cycle and apoptosis. Protein analysis was conducted by western blot. Cell migration and invasion were determined using transwell assay. Target relation was analyzed using dual‐luciferase reporter and RNA immunoprecipitation (RIP) assays. The function of GL63 in vivo was researched by xenograft model in mice. RESULTS: GL63 inhibited the circZNF83 expression in HCC cells. CircZNF83 overexpression attenuated the inhibitory effects of GL63 on HCC cell growth, cell cycle progression, migration, and invasion but the promoting effect on cell apoptosis. CircZNF83 served as a sponge of miR‐324‐5p and circZNF83/miR‐324‐5p axis was involved in the functional regulation of GL63 in HCC progression. Moreover, CDK16 was a downstream target of miR‐324‐5p and circZNF83 could regulate the CDK16 expression by sponging miR‐324‐5p. The anti‐tumor function of GL63 was also related to the miR‐324‐5p/CDK16 axis. In addition, GL63 inactivated the JAK2/STAT3 pathway via downregulating circZNF83 to mediate the miR‐324‐5p/CDK16 axis. GL63 also repressed tumor growth in vivo through the circZNF83/miR‐324‐5p/CDK16‐mediated JAK2/STAT3 signal inhibition. CONCLUSION: This study suggested GL63 impeded the HCC development by blocking the JAK2/STAT3 signaling pathway via mediating the circZNF83/miR‐324‐5p/CDK16 axis.
format Online
Article
Text
id pubmed-8518784
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-85187842021-10-21 A curcumin analog GL63 inhibits the malignant behaviors of hepatocellular carcinoma by inactivating the JAK2/STAT3 signaling pathway via the circular RNA zinc finger protein 83/microRNA‐324‐5p/cyclin‐dependent kinase 16 axis Zhao, Ji‐an Nie, Wenjia Dong, Liang Liu, Wencong Wei, Wei J Gastroenterol Hepatol Experimental Hepatology BACKGROUND AND AIM: (1E,4E)‐1,5‐bis(2‐bromophenyl) penta‐1,4‐dien‐3‐one (GL63) is a curcumin analog that can protect against carcinogenesis in hepatocellular carcinoma (HCC). The aim of this study was to explore the molecular mechanism of GL63 in HCC. METHODS: Cell viability was examined by cell counting kit‐8 (CCK‐8) assay. Circular RNA zinc finger protein 83 (circZNF83), microRNA‐324‐5p (miR‐324‐5p), and cyclin‐dependent kinase 16 (CDK16) levels were measured via the quantitative real‐time polymerase chain reaction (qRT‐PCR). Cell proliferation was assessed using colony formation assay. Flow cytometry was performed for detecting cell cycle and apoptosis. Protein analysis was conducted by western blot. Cell migration and invasion were determined using transwell assay. Target relation was analyzed using dual‐luciferase reporter and RNA immunoprecipitation (RIP) assays. The function of GL63 in vivo was researched by xenograft model in mice. RESULTS: GL63 inhibited the circZNF83 expression in HCC cells. CircZNF83 overexpression attenuated the inhibitory effects of GL63 on HCC cell growth, cell cycle progression, migration, and invasion but the promoting effect on cell apoptosis. CircZNF83 served as a sponge of miR‐324‐5p and circZNF83/miR‐324‐5p axis was involved in the functional regulation of GL63 in HCC progression. Moreover, CDK16 was a downstream target of miR‐324‐5p and circZNF83 could regulate the CDK16 expression by sponging miR‐324‐5p. The anti‐tumor function of GL63 was also related to the miR‐324‐5p/CDK16 axis. In addition, GL63 inactivated the JAK2/STAT3 pathway via downregulating circZNF83 to mediate the miR‐324‐5p/CDK16 axis. GL63 also repressed tumor growth in vivo through the circZNF83/miR‐324‐5p/CDK16‐mediated JAK2/STAT3 signal inhibition. CONCLUSION: This study suggested GL63 impeded the HCC development by blocking the JAK2/STAT3 signaling pathway via mediating the circZNF83/miR‐324‐5p/CDK16 axis. John Wiley and Sons Inc. 2021-06-03 2021-10 /pmc/articles/PMC8518784/ /pubmed/33982329 http://dx.doi.org/10.1111/jgh.15545 Text en © 2021 The Authors. Journal of Gastroenterology and Hepatology published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Experimental Hepatology
Zhao, Ji‐an
Nie, Wenjia
Dong, Liang
Liu, Wencong
Wei, Wei
A curcumin analog GL63 inhibits the malignant behaviors of hepatocellular carcinoma by inactivating the JAK2/STAT3 signaling pathway via the circular RNA zinc finger protein 83/microRNA‐324‐5p/cyclin‐dependent kinase 16 axis
title A curcumin analog GL63 inhibits the malignant behaviors of hepatocellular carcinoma by inactivating the JAK2/STAT3 signaling pathway via the circular RNA zinc finger protein 83/microRNA‐324‐5p/cyclin‐dependent kinase 16 axis
title_full A curcumin analog GL63 inhibits the malignant behaviors of hepatocellular carcinoma by inactivating the JAK2/STAT3 signaling pathway via the circular RNA zinc finger protein 83/microRNA‐324‐5p/cyclin‐dependent kinase 16 axis
title_fullStr A curcumin analog GL63 inhibits the malignant behaviors of hepatocellular carcinoma by inactivating the JAK2/STAT3 signaling pathway via the circular RNA zinc finger protein 83/microRNA‐324‐5p/cyclin‐dependent kinase 16 axis
title_full_unstemmed A curcumin analog GL63 inhibits the malignant behaviors of hepatocellular carcinoma by inactivating the JAK2/STAT3 signaling pathway via the circular RNA zinc finger protein 83/microRNA‐324‐5p/cyclin‐dependent kinase 16 axis
title_short A curcumin analog GL63 inhibits the malignant behaviors of hepatocellular carcinoma by inactivating the JAK2/STAT3 signaling pathway via the circular RNA zinc finger protein 83/microRNA‐324‐5p/cyclin‐dependent kinase 16 axis
title_sort curcumin analog gl63 inhibits the malignant behaviors of hepatocellular carcinoma by inactivating the jak2/stat3 signaling pathway via the circular rna zinc finger protein 83/microrna‐324‐5p/cyclin‐dependent kinase 16 axis
topic Experimental Hepatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518784/
https://www.ncbi.nlm.nih.gov/pubmed/33982329
http://dx.doi.org/10.1111/jgh.15545
work_keys_str_mv AT zhaojian acurcuminanaloggl63inhibitsthemalignantbehaviorsofhepatocellularcarcinomabyinactivatingthejak2stat3signalingpathwayviathecircularrnazincfingerprotein83microrna3245pcyclindependentkinase16axis
AT niewenjia acurcuminanaloggl63inhibitsthemalignantbehaviorsofhepatocellularcarcinomabyinactivatingthejak2stat3signalingpathwayviathecircularrnazincfingerprotein83microrna3245pcyclindependentkinase16axis
AT dongliang acurcuminanaloggl63inhibitsthemalignantbehaviorsofhepatocellularcarcinomabyinactivatingthejak2stat3signalingpathwayviathecircularrnazincfingerprotein83microrna3245pcyclindependentkinase16axis
AT liuwencong acurcuminanaloggl63inhibitsthemalignantbehaviorsofhepatocellularcarcinomabyinactivatingthejak2stat3signalingpathwayviathecircularrnazincfingerprotein83microrna3245pcyclindependentkinase16axis
AT weiwei acurcuminanaloggl63inhibitsthemalignantbehaviorsofhepatocellularcarcinomabyinactivatingthejak2stat3signalingpathwayviathecircularrnazincfingerprotein83microrna3245pcyclindependentkinase16axis
AT zhaojian curcuminanaloggl63inhibitsthemalignantbehaviorsofhepatocellularcarcinomabyinactivatingthejak2stat3signalingpathwayviathecircularrnazincfingerprotein83microrna3245pcyclindependentkinase16axis
AT niewenjia curcuminanaloggl63inhibitsthemalignantbehaviorsofhepatocellularcarcinomabyinactivatingthejak2stat3signalingpathwayviathecircularrnazincfingerprotein83microrna3245pcyclindependentkinase16axis
AT dongliang curcuminanaloggl63inhibitsthemalignantbehaviorsofhepatocellularcarcinomabyinactivatingthejak2stat3signalingpathwayviathecircularrnazincfingerprotein83microrna3245pcyclindependentkinase16axis
AT liuwencong curcuminanaloggl63inhibitsthemalignantbehaviorsofhepatocellularcarcinomabyinactivatingthejak2stat3signalingpathwayviathecircularrnazincfingerprotein83microrna3245pcyclindependentkinase16axis
AT weiwei curcuminanaloggl63inhibitsthemalignantbehaviorsofhepatocellularcarcinomabyinactivatingthejak2stat3signalingpathwayviathecircularrnazincfingerprotein83microrna3245pcyclindependentkinase16axis